Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Milk Thistle Derivative Silibinin(A) as a Potential Anti-obesity Agent

NCT05069298 is registered in ClinicalTrials.gov with Universidad Católica San Antonio de Murcia as lead sponsor.

NCT NCT05069298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05069298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Milk Thistle Derivative Silibinin(A) as a Potential Anti-obesity Agent
Lead sponsor
Universidad Católica San Antonio de Murcia
Phase
Not applicable
Overall status
Unknown status
Start date
January 12, 2023
Completion date
December 21, 2023
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolemia, hypertriglyceridemia, overweight and obesity